Relative value of prostate-specific antigen and prosttic acid phosphatase in diagnosis and management of adenocarcinoma of prostate Ohio State University Experience
Authors:
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Contribution of Bone Scintigraphy, Prostatic Acid Phosphatase and Prostate-Specific Antigen to the Monitoring of Prostatic CancerEuropean Urology, 1988
- Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the ProstateNew England Journal of Medicine, 1987
- Tumour Markers in Prostatic Carcinoma. A Comparison of Prostate‐specific Antigen with Acid PhosphataseBritish Journal of Urology, 1987
- Prostatic Acid Phosphatase: Its Current Clinical StatusJournal of Urology, 1987
- Evaluation of prostate-specific antigen and prosttic acid phosphatase as prostate cancer markersUrology, 1986
- Natural History and Staging of Prostate CancerUrologic Clinics of North America, 1984
- EFFECTS OF MISCLASSIFICATIONS ON STATISTICAL INFERENCES IN EPIDEMIOLOGYAmerican Journal of Epidemiology, 1980
- Sodium Thymolphthalein Monophosphate: A New Acid Phosphatase Substrate with Greater Specificity for the Prostatic Enzyme in SerumClinical Chemistry, 1971
- Chi-Square Tests with One Degree of Freedom; Extensions of the Mantel- Haenszel ProcedureJournal of the American Statistical Association, 1963
- AN “ ACID ” PHOSPHATASE OCCURRING IN THE SERUM OF PATIENTS WITH METASTASIZING CARCINOMA OF THE PROSTATE GLANDJournal of Clinical Investigation, 1938